KEYSTONE INVESTORS PTE LTD

Position in ARWR — Arrowhead Pharmaceuticals, Inc.

CIK 1926253 SINGAPORE, U0

Position in ARWR

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$7,715,818

+$3,871,837 QoQ

Shares Held

94,661

+63.5% QoQ

Ownership

0.067%

of shares outstanding

% of Portfolio

0.41%

of 13F equity value

Holder Rank

#111

of 497 holders

Holding Since

Dec 2025

2 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

KEYSTONE INVESTORS PTE LTD holds $26,469,333 across 3 Biotechnology names. ARWR ranks #2 (29.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	BNTX	BioNTech SE	153,466	$14,280,011
2	ARWR	Arrowhead Pharmaceuticals, Inc. This page	94,661	$7,715,818
3	DFTX	Definium Therapeutics, Inc.	95,100	$4,473,504

2 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$7,715,818	94,661	+63.5%	Shares	Sole	2026-08-14
2025-12-31	$3,843,981	57,900	—	Shares	Sole	2026-02-13
No filing history on record for this holder in this stock.